Understanding the effect of RSU1P2 on the cellular malignancy will help elucidate the pathogenesis of aggressive cervical carcinoma and provide a basis for novel targeted therapies for cervical carcinoma treatment. The gene discussed is RSU1P2; the disease is cervical carcinoma.